I’ve been thinking a lot about drug consumption rooms lately
– often referred to in the field as DCRs.
They’ve been an issue nationally, with the
debates around the Glasgow proposal as well as noises from Durham and
other
places. And it’s no secret that drug-related
litter has been an issue in Bournemouth
and Weymouth,
which my job covers, so it’s a day-to-day thing too.
The arguments are pretty familiar. There’s not any real doubt that these
facilities can have a positive impact for people who use drugs and the wider
community. However, there’s a debate
about the scale of that impact and whether
scarce resources are best spent on these kinds of facilities rather than other,
more established, initiatives. We’re
never going to live in a utopia where everything that everyone needs or wants
is funded and so these questions are real: what would we be trying to achieve
with DCRs, and would it be worth it?
(For those of you who don’t follow these debates in as much
detail as me, the term DCR can cover a range of things, but generally means
somewhere to inject drugs under supervision.
The arguments in favour are that they reduce risks to people who use
drugs as they have somewhere cleaner and safer, where someone is checking that
they’re OK – but it’s not just about the users themselves, as they can
potentially reduce public use and drug-related litter as well as drug-related
crime. If you want a good summary, Glasgow
and Southampton
councils have done great work on this.)
The
view of the ACMD is that DCRs might be useful, but as part of a wider
package of interventions; they shouldn’t be seen as a panacea on their
own. That is, of course, fair, but it’s
not the most practical advice for commissioners who are struggling with increasing
numbers of drug-related deaths, an ageing cohort of people who aren’t making
great progress in treatment, and rising rates of homelessness and public
injecting. A comprehensive package of
interventions would be great, but we didn’t have that in 2010, and now we’ve
got cuts of 20% already, with no
funding at all guaranteed beyond 2020.
So can – or rather should – DCRs be part of the picture in
terms of commissioning under austerity?
When this debate comes up, it’s often framed in terms of the
‘methadone
wars’ – that harm reduction has been sacrificed on the altar of
‘recovery’. But (and I’m not alone on
this, it’s not an original thought) I can’t get my head around this invented
binary. How does anyone achieve recovery
without reducing the harm from their substance use? How can giving someone advice and information
about substance use be counterproductive to them achieving recovery? Or, putting it bluntly: you can’t recover if
you’re dead.
And a lot of people who use drugs are dying. I don’t think this can be overstated – though
it’s
not necessarily the most powerful political argument in favour of drug
treatment.
But setting aside this idea that treatment has been damaged
by a focus on recovery or ‘successful completions’ (which I appreciate is some
people’s experience, but it’s not mine), if we’re coming at this issue fresh,
without the baggage of previous political debates, what should we do about
DCRs?
Well the first point I often hear is that we should (to reference
John Major) get ‘back to basics’. If
only we did needle exchange (and possibly opiate substitution treatment [OST])
properly, then there wouldn’t be these issues.
I’m informed that we’ve lost specialist needle exchanges and pharmacies
offer a poor replacement.
But I don’t recognise this picture. Commissioners find contracting with
pharmacies frustrating: there’s lots of them and their local authority
‘business’ (whether needle exchange, supervised consumption of methadone or
sexual health services) is a fraction of the overall turnover from NHS England
or the commercial side of their work.
You can’t effectively manage a hundred contracts of this type. The provider doesn’t care about your element
of the service that much, and as a commissioner you can’t spare the time or
energy to manage each one of them with the same intensity you’d apply to a
specialist provider. So inevitably the
service isn’t great.
But that’s no criticism.
In fact, it’s in line with NICE guidelines, which suggest
a tiered approach to needle exchange where specialist services offer the gold
standard, including harm reduction advice, but we can’t provide that in every
neighbourhood and indeed this level of involvement might put some people off,
so we need to offer accessible facilities in a wide range of locations
too. It wouldn’t be possible to have a
specialist needle exchange in every town or village in Dorset, but it’s
possible to deliver this through pharmacies – though inevitably at a lower
level of intensity.
I just don’t recognise the picture I’ve seen (or rather
heard) painted that commissioners have lost all the structure and experience of
30 years ago, seen as the heyday of harm reduction. Maybe it’s true elsewhere, but although we’re
always able to improve our needle exchange offer, and the past few years
haven’t been ideal, I can’t see that we’re moving away from specialist services
to pharmacies.
If anything, as I say, I would have thought that the public
health experience of having to directly commission pharmacies to do all sorts
of bits and bobs that you wouldn’t have thought were the local authority’s
responsibility (the morning after pill, for example) would have made
commissioners more reluctant to use this as some kind of efficient escape route
from the problems they’re facing.
There’s more uncertainty and less control – how’s that a recipe to sleep
easier at night?
The issue is more likely to be integration – not only
between pharmacies and the wider treatment system, but simply between needle
exchange and more structured treatment. I’ve
been told that many service users actually prefer using pharmacy needle
exchanges to the specialist services -precisely because they don’t get those
hassling harm reduction initiatives or people trying to engage them into
‘structured’ treatment.
And that’s where we get to a really difficult point.
DCRs are often sold, following the ACMD argument, as an
opportunity to engage people into treatment.
A DCR can be a hub for the full range of harm reduction activities and
wider social interventions like housing, benefits, employment, probation and so
on. The argument is that some of the
people most in need of support are going to come into this facility, so it’s an
opportunity to get a whole range of ‘wrap around’ services put in place as part
of a broader treatment ‘plan’.
But most DCRs aren’t just harm reduction hubs; they also
offer – for example in the Glasgow proposal – structured treatment, often
heroin assisted treatment. Certainly
there’s all sorts of services operating from most, from methadone dispensing to
housing benefit advice. That can sound
like a great idea; an opportunity to engage people straight from injecting
illicit substances to being on a legal prescription.
But equally it can sound like the opposite of what some harm
reduction advocates would hope.
In Weymouth, we have brought all our services under one
roof. There used to be a site for
prescribing, a site for harm reduction and group work, and a site for the
criminal justice team. And then the
abstinence-based ‘aftercare’ operated from a range of sites (like church halls)
that weren’t permanent fixtures.
(It’s not just austerity that brought services together;
it’s also service user feedback. One
(unnamed) individual used what’s become known locally as ‘the dentist analogy’:
imagine if you had to go one place to have your anaesthetic, then walk down the
road to get your tooth drilled, then hop on a bus to then get the filling
actually put in. That’s what dealing
with substance misuse treatment (and all the other related services) felt like
to them. Saving on rental costs by
sharing premises won’t dig us out of our financial hole; one member of staff
can cost more than the rent on a workable building – just check rightmove. It’s the people that make the difference in
services, and quite rightly that’s what commissioners are mostly paying for.)
So what’s the problem with bringing services under one roof,
as they would be to some extent with a DCR?
Well, it means that by definition you don’t have dedicated harm
reduction services; they’re operating from the same premises as the prescribing
provider who will be (more often than not) part of the NHS. So our needle exchange now operates from the
Weymouth Community Hospital site. Since
it moved from a dedicated third-sector ‘drug agency’ base, the numbers
accessing needle exchange there have fallen.
People, we’re told, find it intimidating to access needle exchange at
the same site where they pick up their prescription. (And equally, people who are now abstinent
find it a challenge to step through the door of a facility where people are
still in ‘active addiction’.)
I appreciate this is rambling. I haven’t got (as I often ask for in the day
job) a clear definition of ‘the problem’ or a proposed ‘solution’. But that’s the point. A lot of people (including me) are excited by
DCRs, but if I’m honest that’s partly because they’re shiny and new to a UK audience
– and therefore untainted and full of promise.
On this blog I’ve often moaned about how minimum
unit pricing for alcohol is an empty vessel into which people pour all their
(alcohol policy) desires: it’ll stop underage drinking, binge drinking,
dependent drinking, excessive everyday drinking, and so on. It’ll even revive the pub trade.
I worry that DCRs will become the same thing
for drug policy: they’ll reduce drug-related litter, public injecting, blood
borne viruses, crime, antisocial behaviour, and they’ll foster recovery and
abstinence while they’re at it.
Will DCRs really be a harm reduction hub? And if they are, should they also be a site
for delivering treatment? Or will that
scare people off? (Both people who
aren’t ready for treatment and those who want to see a bit more stability in
their lives.) To return to my regular
themes on this blog, I think we need to work out what we’re trying to achieve
before we start leaping to solutions.